Orange Book product · Generic (ANDA)
CLOXACILLIN SODIUM
CLOXACILLIN SODIUM
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CLOXACILLIN SODIUM
Strength
EQ 250MG BASE
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
ANDA 062240
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLOXACILLIN SODIUM
- —TEGOPENBrand (NDA)
NDA 050192 · APOTHECON
- 1989CLOXACILLIN SODIUMGeneric (ANDA)
ANDA 062978 · TEVA
- —CLOXACILLIN SODIUMGeneric (ANDA)
ANDA 061452 · APOTHECON
- —CLOXAPENGeneric (ANDA)
ANDA 061806 · GLAXOSMITHKLINE
- —CLOXAPENGeneric (ANDA)
ANDA 062233 · GLAXOSMITHKLINE
- —CLOXACILLIN SODIUMGeneric (ANDA)
ANDA 062268 · TEVA
- —TEGOPENGeneric (ANDA)
ANDA 061453 · APOTHECON
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
